MDGL
#802
Madrigal Pharmaceuticals, Inc. - Common Stock
538.7 0 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.34%
Variación mensual
+6.65%
Variación en los últimos 6 meses
+8.66%
Cambio anual
+27.17%
Cierres anteriores
536.8 6
Open
536.0 5
Mínimo
529.7 5
High
540.2 1
Volumen
54
Financials
- Market Capitalization 12.42 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-34.99
Relación precio/flujo de caja
11.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 708 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 238.88 USD | +0.35% | -2.87% | +3.47% | +70.63% | 14.99 B USD | ||
| 734 |  EXEL Exelixis, Inc. - Common Stock | 55.46 USD | -0.56% | -1.63% | +3.97% | +42.06% | 13.94 B USD | ||
| 816 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 232.72 USD | -1.08% | -5.95% | -8.75% | +78.74% | 11.98 B USD | ||
| 823 |  SMMT Summit Therapeutics Inc. - Common Stock | 15.49 USD | +0.13% | -2.21% | +9.70% | -22.00% | 12.02 B USD |